Anna Grenda

979 total citations
56 papers, 608 citations indexed

About

Anna Grenda is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Grenda has authored 56 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Grenda's work include Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Lung Cancer Research Studies (9 papers). Anna Grenda is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Lung Cancer Research Studies (9 papers). Anna Grenda collaborates with scholars based in Poland, Sweden and Norway. Anna Grenda's co-authors include Paweł Krawczyk, Janusz Milanowski, K. Kwiatek, Tomasz Grenda, Kamila Wojas‐Krawczyk, Ewa Kalinka‐Warzocha, Agata Filip, Marcin Nicoś, Izabela Chmielewska and Michał Szczyrek and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Applied Microbiology and Biotechnology.

In The Last Decade

Anna Grenda

49 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Grenda Poland 15 284 207 133 122 88 56 608
Martina Klünemann Germany 5 446 1.6× 126 0.6× 111 0.8× 91 0.7× 108 1.2× 9 687
Yifeng Lin China 12 459 1.6× 168 0.8× 110 0.8× 80 0.7× 120 1.4× 16 661
Cheng‐Bei Zhou China 9 329 1.2× 164 0.8× 66 0.5× 86 0.7× 81 0.9× 12 479
Xiaoya Ma China 14 343 1.2× 125 0.6× 161 1.2× 73 0.6× 112 1.3× 27 810
Wing Yin Cheng Hong Kong 10 521 1.8× 175 0.8× 199 1.5× 63 0.5× 60 0.7× 11 720
Zhuang Jing China 15 340 1.2× 133 0.6× 112 0.8× 100 0.8× 39 0.4× 48 508
Lingfeng Fu Japan 7 328 1.2× 113 0.5× 77 0.6× 49 0.4× 82 0.9× 9 537
Maria Massucci Italy 11 255 0.9× 228 1.1× 51 0.4× 181 1.5× 68 0.8× 17 722
Yonglie Zhou China 12 198 0.7× 92 0.4× 73 0.5× 99 0.8× 104 1.2× 32 531
Keqing Qian China 12 319 1.1× 190 0.9× 263 2.0× 66 0.5× 240 2.7× 26 797

Countries citing papers authored by Anna Grenda

Since Specialization
Citations

This map shows the geographic impact of Anna Grenda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Grenda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Grenda more than expected).

Fields of papers citing papers by Anna Grenda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Grenda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Grenda. The network helps show where Anna Grenda may publish in the future.

Co-authorship network of co-authors of Anna Grenda

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Grenda. A scholar is included among the top collaborators of Anna Grenda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Grenda. Anna Grenda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jakubczyk, Anna, Kamila Rybczyńska‐Tkaczyk, & Anna Grenda. (2025). Plant Antimicrobial Oligopeptides with Anticancer Properties as a Source of Biologically Active Peptides—An In Silico Study. International Journal of Molecular Sciences. 26(18). 9189–9189.
2.
Grenda, Anna, Barbara Kuźnar-Kamińska, Arkadiusz Bomba, et al.. (2025). Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients. Scientific Reports. 15(1). 6139–6139. 6 indexed citations
3.
Grenda, Tomasz, et al.. (2024). The usefulness of botulinum toxin injections in oncology – Clinical and laboratory perspectives. European Journal of Pharmacology. 987. 177196–177196.
4.
Gaweł, Kinga, Marta Marszałek‐Grabska, Anna Grenda, et al.. (2024). Induction of seizures and initiation of epileptogenesis by pilocarpine in zebrafish larvae. Frontiers in Molecular Neuroscience. 17. 1418606–1418606. 2 indexed citations
5.
Krawczyk, Paweł, et al.. (2024). Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection. International Journal of Molecular Sciences. 25(11). 5893–5893. 25 indexed citations
6.
Grenda, Tomasz, Anna Grenda, Anna Jakubczyk, & Kamila Rybczyńska‐Tkaczyk. (2024). Opportunistic Features of Non-Clostridium botulinum Strains Containing bont Gene Cluster. Pathogens. 13(9). 780–780.
7.
Grenda, Tomasz, et al.. (2023). Molecular Diversity of BoNT-Producing Clostridia—A Still-Emerging and Challenging Problem. Diversity. 15(3). 392–392. 2 indexed citations
8.
Grenda, Tomasz, et al.. (2023). Clostridium perfringens—Opportunistic Foodborne Pathogen, Its Diversity and Epidemiological Significance. Pathogens. 12(6). 768–768. 32 indexed citations
11.
Huang, Jiayuan, Jie Ni, Meng Song, et al.. (2023). Transformation of ALK-positive NSCLC to SCLC after alectinib resistance and response to combined atezolizumab: a case report. Translational Lung Cancer Research. 12(3). 637–646. 10 indexed citations
12.
Mądro, Agnieszka, et al.. (2023). Circulating microRNAs as a potential diagnostic marker in chronic pancreatitis, pancreatic cancer and colorectal cancer. Oncology in Clinical Practice. 19(1). 34–42. 3 indexed citations
13.
Grenda, Anna, Tomasz Grenda, Piotr Domaradzki, & K. Kwiatek. (2022). Enterococci—Involvement in Pathogenesis and Therapeutic Potential in Cancer Treatment: A Mini-Review. Pathogens. 11(6). 687–687. 10 indexed citations
14.
Grenda, Tomasz, Anna Grenda, Piotr Domaradzki, Paweł Krawczyk, & K. Kwiatek. (2022). Probiotic Potential of Clostridium spp.—Advantages and Doubts. Current Issues in Molecular Biology. 44(7). 3118–3130. 34 indexed citations
15.
Szczyrek, Michał, Anna Grenda, Barbara Kuźnar-Kamińska, et al.. (2021). Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer. Cancers. 13(23). 6139–6139. 5 indexed citations
16.
Krawczyk, Paweł, Anna Grenda, Kamila Wojas‐Krawczyk, et al.. (2021). Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement. Scientific Reports. 11(1). 20939–20939. 6 indexed citations
17.
Grenda, Anna & Paweł Krawczyk. (2021). Cancer trigger or remedy: two faces of the human microbiome. Applied Microbiology and Biotechnology. 105(4). 1395–1405. 11 indexed citations
18.
Grenda, Anna, Michał Szczyrek, Paweł Krawczyk, et al.. (2019). Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients. Cancer Medicine. 9(2). 605–614. 23 indexed citations
19.
Grenda, Anna & Monika Skowrońska. (2004). Nowe trendy w badaniach nad biogeochemia krzemu. Zeszyty Problemowe Postępów Nauk Rolniczych. 502(2). 781–789. 1 indexed citations
20.
Grenda, Anna, et al.. (2001). Wpływ obecności kadmu w środowisku glebowym na akumulację K, Mg, Ca i Cd w pszenicy twardej (Triticum turgidum l. var durum) na tle zastosowanych środków wiążących. 6(4). 457–465. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026